(Press-News.org) Washington, DC -- New research from Georgetown University Medical Center (GUMC) suggests that up to 40 percent of scleroderma patients will not be correctly diagnosed with the disorder using a new automated commercial screening test. The findings of the study will be presented Wednesday, November 10th at the Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia.
The American College of Rheumatology recommends immunofluorescence antinuclear antibody (IF-ANA) testing to help detect the presence of scleroderma specific antinuclear antibodies. Finding the antibodies is a helpful predictor of disease manifestations, clinical course and outcome in scleroderma. However, many commercial labs have recently adopted a newer, automated method that use non-immunofluorescence antinuclear antibody testing. This test is known as NEW ANA.
To test the accuracy of the commercial method for detecting scleroderma antibodies, GUMC researchers evaluated the all test results performed through commercial laboratories of more than 200 scleroderma patients treated in the Georgetown scleroderma clinic between June 2008 and June 2009.
Test results using NEW ANA were available in 58 scleroderma patients. Twenty-eight patients (48 percent) tested negative. Of these 28 patients, 22 had either positive results using IF-ANA or one of the scleroderma specific antibodies. "The NEW ANA testing, that is the ANA test without immunofluorescence, failed to identify patients with a particular subset of scleroderma specific antinuclear antibodies and other patterns that are picked up with IF ANA testing. This finding was significant," says Victoria K Shanmugam, MBBS, MRCP, assistant professor in the Division of Rheumatology, Immunology and Allergy who presented the findings.
NEW ANA test results were not available for the remaining 183 scleroderma patients. IF ANA testing was conducted in these patients and the positive antibody results were divided by subtypes.
"Given what we know about the subsets that are not detected by the NEW ANA testing, it appears that as many as 40 percent of the scleroderma patients would have tested negative using the new commercial testing method," Shanmugam says. "If a clinician has clinical suspicion for scleroderma, they should order the immunofluorescent ANA."
###
Shanmugam's research is funded by the American College of Rheumatology, Research and Education Foundation, Physician Scientist Development Award and from the National Center for Research Resources.
The authors report no potential financial interests.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Georgetown Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO). In fiscal year 2009-2010, GUMC accounted for 79 percent of Georgetown University's extramural research funding.
Podium presentation: Wednesday, November 10, 2010, 5:45 pm
Abstract: [2197] - Antinuclear Antibody Screening in Systemic Sclerosis.
Donna Rose Swistowski, MD1,Nicole Saddic, MD2,Victoria K Shanmugam, MBBS, MRCP3,Virginia D Steen, MD4. 1Georgetown University Division of Rheumatology, Immunology, and Allergy, Bethesda, MD,2Georgetown University Hospital Department of Medicine,3Georgetown University Division of Rheumatology, Immunology, and Allergy,4Department of Rheumatology, Georgetown University Medical Center, Washington, DC
Purpose: Scleroderma specific antinuclear antibodies (SScAB) are helpful predictors of disease manifestations, clinical course and outcome in scleroderma. Historically, immunofluorescence (IF) antinuclear antibody (ANA) testing was the gold standard method for ANA detection, and the American College of Rheumatology continues to recommend IF for evaluation of ANA. Many commercial labs have recently adopted newer, automated, non-immunofluorescence methods (NEW ANAs), such as EIA (enzyme immunoassay) or immunobead methods to evaluate for the presence of antinuclear antibodies. These new techniques rely on a limited panel of autoantigens in the assay.
The purpose of this study was to evaluate ANAs and SScAB results performed through commercial labs, using both NEW ANA detection techniques and traditional IF, in a consecutive cohort of scleroderma patients seen in the Georgetown Scleroderma Clinic over a one year period.
Methods: Between June 2008 and June 2009, 241 scleroderma patients were evaluated. Patient charts were reviewed for results of NEW ANA, IF-ANA, isolated nucleolar ANA pattern (NuANA), and the SScAB profile including anticentromere (ACA), anti-topoisomerase (Scl-70), U1 RNP, and RNA polymerase III (Pol III) antibodies.
Results: The results of this study are summarized in table 1. NEW ANA results were available in 58 patients with 28 patients (48%) testing negative. Of these 28 patients, 22 had either positive IF-ANA or a SScAB recorded: IF-ANA only (n=7), NuANA (n=6), Pol III (n=7), SSB (n=1), U1 RNP (n=1). In the patients with a positive NEW ANA (n=30) the NEW ANA successfully detected all patients with ACA (n=4), Scl-70 (n=13), UI RNP (n=6), and SSA (n=1) antibodies. A positive NEW ANA additionally identified Pol III (n=1), NuANA with a + SSA (n=3), and nonspecific ANA (n=2). However, the NEW ANA failed to identify the NuANA, Pol III antibodies, and other IF-ANA patterns in a significant number of patients (20/22 vs. 6/30, p END
Philadelphia, Pa. – Examining the blood "metabolomics" profile of smokers immediately after they had a cigarette revealed activation of pathways involved in cell death, inflammation, and other forms of systemic damage, say researchers at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center.
They say their findings, presented at the Ninth AACR Frontiers in Cancer Prevention Research Meeting, is the best analysis for chemicals unequivocally produced by smoking and indicates the potential toll that carcinogens and toxins poise to ...
CHAPEL HILL, N.C. – In the largest study to date of the Arthritis Foundation's Tai Chi program, participants showed improvement in pain, fatigue, stiffness and sense of well-being.
Their ability to reach while maintaining balance also improved, said Leigh Callahan, PhD, the study's lead author, associate professor in the University of North Carolina at Chapel Hill School of Medicine and a member of UNC's Thurston Arthritis Research Center.
"Our study shows that there are significant benefits of the Tai Chi course for individuals with all types of arthritis, including ...
Hamilton, ON (November 7, 2010) – In an important breakthrough, scientists at McMaster University have discovered how to make human blood from adult human skin.
The discovery, published in the prestigious science journal Nature today, could mean that in the foreseeable future people needing blood for surgery, cancer treatment or treatment of other blood conditions like anemia will be able to have blood created from a patch of their own skin to provide transfusions. Clinical trials could begin as soon as 2012.
Mick Bhatia, scientific director of McMaster's Stem Cell ...
Hospital for Special Surgery physicians who focus on lupus, scleroderma and related conditions are traveling from New York City to Atlanta this week to share their recent findings at the 74th Annual Scientific Meeting of the American College of Rheumatology (ACR).
Special Surgery investigators will present advances that may influence the future of clinical care. Topics include prevention strategies for helping orthopedic patients avoid falls, quality of life in children with lupus, understanding joint pain caused by a commonly used breast cancer medication, lupus-related ...
Using pests as part of an insect birth control program helps to get rid of them, UA researchers find. A new approach that combines the planting of pest-resistant cotton and releasing large numbers of sterile moths has virtually eliminated of the world's most destructive cotton pests from Arizona.
The novel control strategy, published in the Nov. 7 advance online publication of the journal Nature Biotechnology, has allowed growers to maintain high cotton yields without spraying insecticides to control pink bollworm.
"We are running the pesticide treadmill in reverse," ...
ATLANTA, GA — Lupus puts children at higher risk for coronary artery disease when they become adults, but routinely using statins doesn't provide enough benefit to warrant their regular use in children and adolescents, according to the largest study of pediatric lupus patients to date.
Lupus is an autoimmune disease that causes widespread inflammation and organ damage. Children with lupus show early signs of atherosclerosis -- the fatty tissue buildup that is the precursor to clogged arteries. Previous research also indicates risk for heart attack and stroke in premenopausal ...
"Anecdotally, we can see the transformative effect," says Dr. Mechael, who, sponsored by the mHealth Alliance, has recently completed an analysis of 2,400 published mHealth reports. Working with WHO, she found that many countries either have already or are considering introducing mHealth into their health systems. mHealth is so new, however, "the data is just not there yet to prove the case," says Dr. Mechael.
Many different groups and organizations are carrying out countless pilot projects. That presents a potential barrier to expansion. "Most projects are designed as ...
St. Louis, MO, November 8, 2010 – The economic recession impacts many aspects of our lives including an increase incidence of food insecurity. This can have serious consequences for those suffering from chronic illnesses like diabetes. For diseases like diabetes, in which nutrition and menu planning play a key role in treatment, food insecurity can be devastating. A study in the November/December issue of the Journal of Nutrition Education and Behavior explores how technology advancement in the form of telemedicine can provide cost-effective ways to treat those with diabetes ...
PHILADELPHIA — Young mice that experienced the psychosocial stress of prolonged separation from their mothers had a higher incidence and faster onset of breast tumors compared with young mice who did not experience this stressful life event. Specifically, neonatal mice separated from their mothers for a prolonged period of time developed mammary tumors twice as fast as mice that experienced short or no maternal separation.
The results of this study, conducted by Leslie Kerr, Ph.D., associate professor of biology and psychology at Trent University, Peterborough, Ontario, ...
A new study has found that women who receive silicone implants after a double mastectomy are more satisfied with their breasts than women who receive saline implants. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help physicians and breast cancer survivors as they together make decisions related to postmastectomy reconstructive surgery.
Women who have one or both of their breasts removed as a treatment for breast cancer may wish to undergo breast reconstructive surgery with implants. Such postmastectomy implants ...
